Jump Financial’s Acadia Pharmaceuticals ACAD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-154,006
| Closed | -$2.83M | – | 1533 |
|
|
2024
Q4 | $2.83M | Sell |
154,006
-12,382
| -7% | -$227K | 0.06% | 413 |
|
|
2024
Q3 | $2.56M | Buy |
166,388
+124,618
| +298% | +$1.92M | 0.05% | 424 |
|
|
2024
Q2 | $679K | Sell |
41,770
-107,233
| -72% | -$1.74M | 0.01% | 987 |
|
|
2024
Q1 | $2.76M | Buy |
149,003
+32,662
| +28% | +$604K | 0.07% | 314 |
|
|
2023
Q4 | $3.64M | Buy |
116,341
+89,053
| +326% | +$2.79M | 0.12% | 182 |
|
|
2023
Q3 | $569K | Sell |
27,288
-50,401
| -65% | -$1.05M | 0.02% | 953 |
|
|
2023
Q2 | $1.86M | Sell |
77,689
-119,221
| -61% | -$2.86M | 0.07% | 419 |
|
|
2023
Q1 | $3.71M | Buy |
+196,910
| New | +$3.71M | 0.15% | 216 |
|
|
2022
Q4 | – | Sell |
-13,100
| Closed | -$214K | – | 1521 |
|
|
2022
Q3 | $214K | Sell |
13,100
-127,669
| -91% | -$2.09M | 0.01% | 1317 |
|
|
2022
Q2 | $1.98M | Buy |
140,769
+74,525
| +113% | +$1.05M | 0.09% | 318 |
|
|
2022
Q1 | $1.6M | Buy |
+66,244
| New | +$1.6M | 0.07% | 344 |
|
|
2021
Q3 | – | Sell |
-79,060
| Closed | -$1.93M | – | 1052 |
|
|
2021
Q2 | $1.93M | Buy |
+79,060
| New | +$1.93M | 0.19% | 114 |
|